ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      85.435
      0.38%
      Bitcoin
      63,322.63
      1.04%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Incyte Corporation (INCY)

      7. Incyte Corporation (INCY) News

      INCY

      Incyte (INCY)

      Incyte Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INCY
      DateTimeSourceHeadlineSymbolCompany
      03/18/20214:30PMBusiness WireIncyte Announces Results from the Phase 3 DEVENT Study Evaluating Ruxolitinib (Jakafi®) as a Treatment for Patients with COV...NASDAQ:INCYIncyte Corporation
      03/11/20218:00AMBusiness WireIncyte Announces Data from Multiple Programs Within its Oncology Portfolio Accepted for Presentation at the AACR Annual Meeti...NASDAQ:INCYIncyte Corporation
      03/03/20214:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      03/03/20217:28AMDow Jones NewsIncyte, Eli Lilly: Baricitinib Meets Main Endpoint in Alopecia Areata StudyNASDAQ:INCYIncyte Corporation
      03/03/20216:45AMPR Newswire (US)Baricitinib is First JAK-Inhibitor to Demonstrate Hair Regrowth in Phase 3 Alopecia Areata (AA) TrialNASDAQ:INCYIncyte Corporation
      02/26/202111:35AMBusiness WireIncyte annonce la validation par l'Agence européenne des médicaments de sa demande d'autorisation de mise sur le marché po...NASDAQ:INCYIncyte Corporation
      02/26/202110:06AMBusiness WireIncyte meldet die von der Europäischen Arzneimittelagentur erteilte Validierung seines Marktzulassungsantrags für Retifanli...NASDAQ:INCYIncyte Corporation
      02/26/20213:00AMBusiness WireIncyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab ...NASDAQ:INCYIncyte Corporation
      02/23/20214:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      02/22/20218:30AMTipRanksIncyte Says FDA Grants Priority Review For Eczema Cream; Street Sees 20% UpsideNASDAQ:INCYIncyte Corporation
      02/22/20218:00AMBusiness WireIncyte Announces Acceptance & Priority Review of sNDA for Jakafi® (ruxolitinib) as a Treatment for Patients with Chronic Gra...NASDAQ:INCYIncyte Corporation
      02/19/20213:02PMBusiness WireIncyte annonce l'acceptation et l'octroi du statut d'examen prioritaire à sa demande de drogue nouvelle (DDN) portant sur la...NASDAQ:INCYIncyte Corporation
      02/19/20211:44PMBusiness WireIncyte meldet Annahme des Zulassungsantrags für Ruxolitinib-Creme gegen atopische Dermatitis im Rahmen eines beschleunigten ...NASDAQ:INCYIncyte Corporation
      02/19/20218:00AMBusiness WireIncyte Announces Acceptance and Priority Review of NDA for Ruxolitinib Cream for Atopic DermatitisNASDAQ:INCYIncyte Corporation
      02/19/20217:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INCYIncyte Corporation
      02/16/20214:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      02/16/202112:24PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INCYIncyte Corporation
      02/11/20218:00AMBusiness WireIncyte to Present at Upcoming Investor ConferenceNASDAQ:INCYIncyte Corporation
      02/10/202111:15AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INCYIncyte Corporation
      02/09/20217:12AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INCYIncyte Corporation
      02/09/20217:00AMBusiness WireIncyte Reports 2020 Fourth Quarter & Year-End Financial Results, Provides 2021 Financial Guidance & Updates on Key Clinical P...NASDAQ:INCYIncyte Corporation
      02/04/20219:38AMEdgar (US Regulatory)Schedule 13gNASDAQ:INCYIncyte Corporation
      02/03/20214:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      01/29/202110:40PMBusiness WireIncyte annonce un avis favorable du CHMP sur le pemigatinib pour le traitement d'adultes atteints d'un cholangiocarcinome loc...NASDAQ:INCYIncyte Corporation
      01/29/20217:55PMBusiness WireIncyte verkündet CHMP-Empfehlung für Pemigatinib zur Behandlung Erwachsener mit zuvor behandeltem, nicht resezierbarem und ...NASDAQ:INCYIncyte Corporation
      01/29/20211:36PMBusiness WireIncyte Announces Positive CHMP Opinion for Pemigatinib for the Treatment of Adults With Previously Treated, Unresectable Loca...NASDAQ:INCYIncyte Corporation
      01/29/202110:01AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INCYIncyte Corporation
      01/27/20215:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      01/27/20215:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      01/27/20215:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
       Showing the most relevant articles for your search:NASDAQ:INCY